prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), covering 2016-03-07 to 2016-03-07. Get the full timeline:
Most recent: EMA Expired: Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics (influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1)) — Novartis Vaccines and Diagnostics S.r.l.